Discover how biotech startup Phagos from Paris, France is using generative AI on AWS to revolutionize the fight against bacterial infections. By training AI to rapidly identify bacteriophages—nature’s own bacteria hunters—they’re creating breakthrough solutions in medical science.
Phagos was selected for the 2024 cohort of the AWS Generative AI Accelerator, which helped to scale their mission. Learn more about the AWS Generative AI Accelerator? https://aws.amazon.com/startups/programs/generative-ai?trk=907a1b46-4000-4185-b704-e1e6937800aa&sc_channel=el
_About Phagos:_
A cutting-edge biotech startup combining AI and bacteriophage technology to develop next-generation treatments for bacterial infections. Learn more: https://go.aws/4duVynj
Subscribe to AWS: https://go.aws/subscribe
Sign up for AWS: https://go.aws/signup
AWS free tier: https://go.aws/free
Explore more: https://go.aws/more
Contact AWS: https://go.aws/contact
Next steps:
Explore on AWS in Analyst Research: https://go.aws/reports
Discover, deploy, and manage software that runs on AWS: https://go.aws/marketplace
Join the AWS Partner Network: https://go.aws/partners
Learn more on how Amazon builds and operates software: https://go.aws/library
Do you have technical AWS questions?
Ask the community of experts on AWS re:Post: https://go.aws/3lPaoPb
Why AWS?
Amazon Web Services (AWS) is the world’s most comprehensive and broadly adopted cloud. Millions of customers—including the fastest-growing startups, largest enterprises, and leading government agencies—use AWS to be more agile, lower costs, and innovate faster.
#AWSStartups, #generativeAI #AWS #Accelerator #AmazonWebServices #CloudComputing
